INEOS Oxide Plaquemine awarded EXCiPACT certification for ethanolamines
Key highlights
- INEOS Oxide's Plaquemine, Louisiana manufacturing site received EXCiPACT certification on 2 July 2021.
- The certification covers pharmaceutical excipients for ethanolamines produced at the Plaquemine site.
- It addresses all GMP-specific elements set out in the 2017 EXCiPACT for Pharmaceutical Excipients standard.
- The certification is intended to support and secure specialty product sales that require an exceptional level of quality assurance.
Certification awarded
After an intense qualification process, INEOS Oxide obtained EXCiPACT certification for pharmaceutical excipients for ethanolamines produced at the Plaquemine, Louisiana manufacturing site on 2 July 2021.
Scope
The certification covers all the GMP-specific elements outlined in the 2017 EXCiPACT for Pharmaceutical Excipients standard, ensuring those parts of the quality management system relevant to GMP are continuously reviewed for compliance and improved upon.
Commercial impact
The company describes the certification as an important achievement that supports and secures specialty product sales requiring an exceptional level of quality assurance.
Source: INEOS